Printer Friendly

COA report: P1.8 B in dengue funds intact.

MANILA, Philippines A portion of the funds allocated by the Department of Health to the Philippine Children's Medical Center (PCMC) for the mass implementation of the previous administration's dengue immunization program remains intact and was in fact deposited in high-yielding accounts, a Commission on Audit (COA) report showed. Based on the COA's audit report on the PCMC, as of Dec.

31, 2016, the state hospital had a total ofP1.865 billion "cash and cash equivalent" that remains intact P1.03 billion of which is under "special high yield savings deposits" P833.234 million under "cash on hand and in banks," and P2.084 million under "time deposits." In its financial statement incorporated in the COA report, the PCMC said part of its remaining P1.865 billion "cash and cash equivalent" is the amount of P1.15 billion recorded under the item "Due to Other Funds-DOH.

" The PCMC clarified the unspent P1.15 billion was "intended for its various health programs and assistance to indigent patients and purchase of dengue vaccines." "Out of the P1.865 billion cash and cash equivalents, P1.219 billion is restricted for the following programs and activities: a) P1.150 billion for DOH programs and assistance and b) P68.985 million for other special hospital-based activities and programs," the COA said.

A year-on-year comparison of the PCMC's "Due to Other Funds DOH" account showed the amount received by the state children's hospital from DOH increased by a whopping 6115 percent or to P1.15 billion in 2016 from P18.501 million in 2015. Headlines ( Article MRec ), pagematch: 1, sectionmatch: 1 Former health secretary Janette Garin had earlier stated it was the PCMC tasked to purchase the dengue vaccines Dengvaxia from multinational pharmaceutical company Sanofi Pasteur as part of the implementation of the Aquino administration's P3.5-billion dengue immunization program in 2015. The audit report, however, showed a slight increase in the amount of PCMC's purchased drugs and medicines to P58.166 million as of the end of 2016 from P34.508 million in 2015.

COPYRIGHT 2017 PhilSTAR Daily, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Philippines Star (Manila, Philippines)
Date:Dec 14, 2017
Words:402
Previous Article:Bato to Bilibid drug lords: See you.
Next Article:China brings solar power to Antique, Palawan.
Topics:

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters